Cargando…
An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy
Methicillin-resistant Staphylococcus aureus (MRSA), including community-associated and hospital-associated strains, is a major cause of human morbidity and mortality. Treatment options have become limited due to the emergence of MRSA strains with decreased sensitivity to vancomycin, which has long b...
Autores principales: | Watkins, Richard R, Lemonovich, Tracy L, File, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526863/ https://www.ncbi.nlm.nih.gov/pubmed/23271985 http://dx.doi.org/10.2147/CE.S33430 |
Ejemplares similares
-
Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010) -
Resolution of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus) osteomyelitis by oral linezolid
por: Gomes, PN, et al.
Publicado: (2003) -
Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012) -
Susceptibility profile of methicillin-resistant Staphylococcus aureus to linezolid in clinical isolates
por: Shariq, Ali, et al.
Publicado: (2017) -
Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections
por: Chhibber, Sanjay, et al.
Publicado: (2013)